Work

Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment

Year: 2019

Type: article

Study design: Observational Study

Source: Journal of Clinical and Experimental Hepatology

DOI: 10.1016/j.jceh.2019.09.001

Authors: Robert J. Wong, Mamta K. Jain, George Therapondos, Mitchell L. Shiffman, Onkar Kshirsagar, Christopher Clark, Mae Thamer

Institutions: Alameda Health System, Highland Hospital, Parkland Health & Hospital System, The University of Texas Southwestern Medical Center, Ochsner Health System, Bon Secours Health System, Bon Secours Liver Institute of Richmond, Medical Technology and Practice Patterns Institute

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, American Association for the Study of Liver Diseases, Gilead Sciences, AbbVie, ViiV Healthcare, CymaBay Therapeutics, Intercept Pharmaceuticals, Janssen Biotech

OpenAlex ID: W2973517385

FWCI: 0.159

Cites: 27

Cited by: 6

Related to: 10